Association Between CD147 Expression, RAS Mutational Status, and Local Recurrence in Resected Locally Advanced Rectal Cancer

ABSTRACT Aim About 5% to 10% of rectal cancer (RC) patients experience local disease recurrence after chemoradiotherapy (CRT) and surgery. Identifying patients at high risk of local recurrence (LR) could lead to the personalized management of the patients. Multiple clinicopathological parameters are...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cancer Medicine
المؤلفون الرئيسيون: Anaëlle Isnard, Laure‐Amandine Cramier, Rémi Vergara, Mehdi Boubaddi, Donatien Fouche, Benjamin Fernandez, Nathalie Senant, Quentin Denost, Éric Rullier, Pierre Dubus, Sandrine Dabernat, Charles Dupin, Véronique Vendrely, Anne Rullier, Samuel Amintas
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Wiley 2025-08-01
الموضوعات:
BRAF
CD147
EMMPRIN
gender
KRAS
local recurrence
الوصول للمادة أونلاين:https://doi.org/10.1002/cam4.71087

الانترنت

https://doi.org/10.1002/cam4.71087

مواد مشابهة